Humacyte Inc.-CW27HUMAWPreferred / convertible

13F holders, Q3 2024 (September 30)
7holders −3
1new positions
4sold out
$1.79avg. 13F price*

At the end of Q3 2024, 7 institutions reported holding Humacyte Inc.-CW27 (HUMAW) in their 13F filings, down 3 from Q2 2024. 1 opened new positions and 4 sold out. The largest holders were LPL Financial LLC ($540K), Wolverine Asset Management LLC ($108K) and Jane Street Group, LLC ($90K).

Company
Humacyte Inc.-CW27
CUSIP
44486Q111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q1 2024: 6Q1 2024Q2 2024: 10Q2 2024Q3 2024: 7Q3 2024Q4 2024: 5Q4 2024Q1 2025: 5Q1 2025Q2 2025: 6Q2 2025Q3 2025: 6Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions1$18K
Exits4$268K

All 13F filers, Q2 2024 → Q3 2024: 10,356 shares bought and 377,414 shares sold, net −367,058 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 7 holders

LPL Financial LLC — No change 300,599 $540K
Wolverine Asset Management LLC — Reduce -25.0% 60,416 $108K
Jane Street Group, LLC — Add +0.7% 50,356 $90K
Cowen and Company, LLC — Reduce -47.6% 49,724 $89K
Sio Capital Management, LLC — No change 49,998 $89K
CSS LLC — Reduce -90.6% 12,846 $23K
Corient Private Wealth LP — New 10,000 $18K

"% of holder's portfolio" is HUMAW's weight in each manager's 13F, not the share of Humacyte Inc.-CW27 the manager owns.